Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability

Human Molecular Genetics

Volumn 24, Issue 14, 2015, Pages 4024-4036

  Su, Chi Ting ^a   Huang, Jenq Wen ^b   Chiang, Chih Kang ^b   Lawrence, Elizabeth C ^a   Levine, Kara L ^a   Dabovic, Branka ^c   Jung, Christine ^d,e   Davis, Elaine C ^f   Madan Khetarpal, Suneeta ^g   Urban, Zsolt ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Practice of Human Genetics   (Germany)

^e SYNLAB ACADEMY   (Germany)

^f MCGILL UNIVERSITY   (Canada)

^g CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 4; MESSENGER RNA; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; LTBP4 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SMAD2 PROTEIN, HUMAN; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ADOLESCENT; ADULT; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1C; AUTOSOMAL RECESSIVE DISORDER; CELL MUTANT; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CUTIS LAXA; DOWN REGULATION; ENDOCYTOSIS; FEMALE; FIBROBLAST; FRAMESHIFT MUTATION; GENE CONTROL; GENE LOSS; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; INTRACELLULAR SIGNALING; LOSS OF FUNCTION MUTATION; LYSOSOME; MALE; MISSENSE MUTATION; MOUSE; NONHUMAN; NONSENSE MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SPLICING DEFECT; YOUNG ADULT; ANIMAL; CASE CONTROL STUDY; CELL CULTURE; CYTOLOGY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; METABOLISM; MUTATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CASE-CONTROL STUDIES; CELLS, CULTURED; CUTIS LAXA; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENDOCYTOSIS; FEMALE; FIBROBLASTS; HUMANS; IMMUNOPRECIPITATION; LATENT TGF-BETA BINDING PROTEINS; MALE; MICE; MICE, KNOCKOUT; MUTATION; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN;

EID: 84936765397     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv139     Document Type: Article

References (31)

1. Hynes, R.O. (2009) The extracellular matrix: not just pretty fibrils. Science, 326, 1216-1219.
2. Todorovic, V. and Rifkin, D.B. (2012) LTBPs, more than just an escort service. J. Cell. Biochem., 113, 410-418.
3. Sterner-Kock, A., Thorey, I.S., Koli, K., Wempe, F., Otte, J., Bangsow, T., Kuhlmeier, K., Kirchner, T., Jin, S., Keski-Oja, J. et al. (2002) Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev., 16, 2264-2273.
4. Urban, Z., Hucthagowder, V., Schurmann, N., Todorovic, V., Zilberberg, L., Choi, J., Sens, C., Brown, C.W., Clark, R.D., Holland, K.E. et al. (2009) Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development. Am. J. Hum. Genet., 85, 593-605.
5. Callewaert, B., Su, C.T., Van Damme, T., Vlummens, P., Malfait, F., Vanakker, O., Schulz, B., Mac Neal, M., Davis, E. C., Lee, J.G. et al. (2013) Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa. Hum. Mutat., 34, 111-121.
6. Dabovic, B., Chen, Y., Choi, J., Vassallo, M., Dietz, H.C., Ramirez, F., von Melchner, H., Davis, E.C. and Rifkin, D.B. (2009) Dual functions for LTBP in lung development: LTBP-4 independently modulates elastogenesis and TGF-beta activity. J. Cell. Physiol., 219, 14-22.
7. Holm, T.M., Habashi, J.P., Doyle, J.J., Bedja, D., Chen, Y., van Erp, C., Lindsay, M.E., Kim, D., Schoenhoff, F., Cohn, R.D. et al. (2011) Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science, 332, 358-361.
8. Neptune, E.R., Frischmeyer, P.A., Arking, D.E., Myers, L., Bunton, T.E., Gayraud, B., Ramirez, F., Sakai, L.Y. and Dietz, H.C. (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet., 33, 407-411.
9. Loeys, B.L., Chen, J., Neptune, E.R., Judge, D.P., Podowski, M., Holm, T., Meyers, J., Leitch, C.C., Katsanis, N., Sharifi, N. et al. (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet., 37, 275-281.
10. Hu, Q., Shifren, A., Choi, J., Szabo, Z., Starcher, B.C., Knutsen, R.H., Shipley, J.M., Davis, E.C., Mecham, R.P. and Urban, Z. (2010) Mechanisms of emphysema in autosomal dominant cutis laxa. Matrix Biol., 29, 621-628.
11. Callewaert, B., Renard, M., Hucthagowder, V., Albrecht, B., Hausser, I., Blair, E., Dias, C., Albino, A., Wachi, H., Sato, F. et al. (2011) New insights into the pathogenesis of autosomal-dominant cutis laxa with report of five ELN mutations. Hum. Mutat., 32, 445-455.
12. Brooke, B.S., Habashi, J.P., Judge, D.P., Patel, N., Loeys, B. and Dietz, H.C. 3rd. (2008) Angiotensin II blockade and aorticroot dilation in Marfan's syndrome. N. Engl. J. Med., 358, 2787-2795.
13. Moustakas, A. and Heldin, C.H. (2009) The regulation of TGFbeta signal transduction. Development, 136, 3699-3714.
14. Shapira, K.E., Gross, A., Ehrlich, M. and Henis, Y.I. (2012) Coated pit-mediated endocytosis of the type I transforming growth factor-beta (TGF-beta) receptor depends on a dileucine family signal and is not required for signaling. J. Biol. Chem., 287, 26876-26889.
15. Qin, H., Shao, Q., Igdoura, S.A., Alaoui-Jamali, M.A. and Laird, D.W. (2003) Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and-competent breast tumor cells. J. Biol. Chem., 278, 30005-30014.
16. Noda, K., Dabovic, B., Takagi, K., Inoue, T., Horiguchi, M., Hirai, M., Fujikawa, Y., Akama, T.O., Kusumoto, K., Zilberberg, L. et al. (2013) Latent TGF-beta binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5. Proc. Natl. Acad. Sci. USA, 110, 2852-2857.
17. Di Guglielmo, G.M., Le Roy, C., Goodfellow, A.F. andWrana, J.L. (2003) Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat. Cell Biol., 5, 410-421.
18. McLean, S. and Di Guglielmo, G.M. (2010) TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II. Biochem. J., 429, 137-145.
19. Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T. and Miyazono, K. (2001) Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem., 276, 12477-12480.
20. Kavsak, P., Rasmussen, R.K., Causing, C.G., Bonni, S., Zhu, H., Thomsen, G.H. andWrana, J.L. (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell., 6, 1365-1375.
21. Hao, X., Wang, Y., Ren, F., Zhu, S., Ren, Y., Jia, B., Li, Y.P., Shi, Y. and Chang, Z. (2011) SNX25 regulates TGF-beta signaling by enhancing the receptor degradation. Cell. Signal., 23, 935-946.
22. Kantola, A.K., Keski-Oja, J. and Koli, K. (2008) Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion. Exp. Cell Res., 314, 2488-2500.
23. Shi, Y., Gochuico, B.R., Yu, G., Tang, X., Osorio, J.C., Fernandez, I.E., Risquez, C.F., Patel, A.S., Shi, Y., Wathelet, M.G. et al. (2013) Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-beta receptor I internalization and inhibiting transforming growth factorbeta1 signaling. Am. J. Respir. Crit. Care. Med., 188, 831-841.
24. Lindsay, M.E. and Dietz, H.C. (2011) Lessons on the pathogenesis of aneurysm from heritable conditions. Nature, 473, 308-316.
25. Margadant, C. and Sonnenberg, A. (2010) Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep., 11, 97-105.
26. Wells, R.G. and Discher, D.E. (2008) Matrix elasticity, cytoskeletal tension, and TGF-beta: the insoluble and soluble meet. Sci. Signal., 1, pe13.
27. Su, C.T., Huang, J.W., Chiang, C.K., Dabovic, B. and Urban, Z. (2014) Latent transforming growth factor beta binding protein 4 enhances renal fibrosis in obstructive uropathy. J. Am. Soc. Nephrol., 25, 732A.
28. Heydemann, A., Ceco, E., Lim, J.E., Hadhazy, M., Ryder, P., Moran, J.L., Beier, D.R., Palmer, A.A. and McNally, E.M. (2009) Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J. Clin. Invest., 119, 3703-3712.
29. Flanigan, K.M., Ceco, E., Lamar, K.M., Kaminoh, Y., Dunn, D. M., Mendell, J.R., King, W.M., Pestronk, A., Florence, J.M., Mathews, K.D. et al. (2013) LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann. Neurol., 73, 481-488.
30. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
31. Abe, M., Harpel, J.G., Metz, C.N., Nunes, I., Loskutoff, D.J. and Rifkin, D.B. (1994) An assay for transforming growth factorbeta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem., 216, 276-284.